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Introduction {#sec1}
============

Adhesion G-protein-coupled receptors (aGPCR) form the second largest of the five heptahelical (i.e., spanning seven transmembranes; 7TM) receptor families ([Figures 1](#fig1){ref-type="fig"}A and [S1](#figs1){ref-type="fig"}A) ([@bib16]; [@bib12], [@bib13]). The receptor class is essential for neuronal development, planar cell and tissue polarity as outlined by mutations throughout the spectrum of multicellular organisms. In humans, aGPCR mutations inflict bilateral frontoparietal polymicrogyria (BFPP) and Usher syndrome type IIc ([@bib28]; [@bib41]). In addition, aGPCR have also been implicated in the pathogenesis of attention deficit and hyperactivity disorder (ADHD) ([@bib2]). Although it is accepted that cell-cell or cell-matrix contact mediated by the extracellular adhesion domains results in receptor signaling ([@bib15]; [@bib35]), the molecular mechanism of aGPCR activation has remained undetermined ([Figure 1](#fig1){ref-type="fig"}A). Prevailing models of aGPCR activation and signaling have emerged from several lines of evidence. First, aGPCR can form distinct multicomponent signaling complexes with other transmembrane molecules in *cis* and in *trans* in an asymmetric layout across a single cell. This mode of signaling has been shown to occur for the cadherin-like aGPCR CELSR/Flamingo (Fmi) of *Drosophila melanogaster* ([@bib37]; [@bib10]). Second, in addition to ligand binding at the N-terminal adhesion domains interaction of a second ligand with the hormone receptor motif (HRM), a domain conserved in many but not all aGPCR, is required for signaling ([@bib32]; [@bib18]). Third, the "split personality" receptor model proposes that N termini of aGPCR are liberated from their 7TM-module posttranslationally via cleavage at the GPS. The ectodomain fragment is then able to recombine with 7TM-modules of other aGPCR at the membrane ([@bib33]).

In this study we have addressed these working models in the prototypical aGPCR *lat-1*, the nematode homolog of Latrophilin/CIRL/LPHN/CL, in an in vivo setting in *Caenorhabditis elegans*.

Results {#sec2}
=======

*lat-1* Is Required for Sperm Function {#sec2.1}
--------------------------------------

We have previously selected *lat-1*, the *C. elegans* homolog of Latrophilin/CIRL/LPHN/CL ([Figure S1](#figs1){ref-type="fig"}B), for investigations into the physiological requirements of a prototype aGPCR ([Figures 1](#fig1){ref-type="fig"}A and [S1](#figs1){ref-type="fig"}B). The null allele *lat-1(ok1465)* causes a distinct tissue polarity defect, which is associated with highly penetrant developmental lethality ([@bib20]). During the screen for postembryonic phenotypes in *lat-1(ok1465)* mutants we discovered a second component of the Lat phenotype owing to a novel function of *lat-1* in the male germline.

Although more than 70% of *lat-1(ok1465)* embryos and larvae fail to develop due to morphological defects, mutant hermaphrodites surviving to adulthood lay a reduced number of fertilized eggs (N2: 228 ± 3.6, n = 177; *lat-1(ok1465)*: 117 ± 4.0, n = 166; p \< 0.0001) and an increased number of unfertilized oocytes (N2: 1.6% ± 0.4%, n = 87; *lat-1(ok1465)*: 18.5% ± 1.9%, n = 81; p \< 0.0001; [Figures 1](#fig1){ref-type="fig"}B and 1C). Expression of transgenic constructs are capable of rescuing polarity phenotypes caused by *lat-1(ok1465)*. This rescue can be read out through the level of developmental lethality in the progeny of transformants ([@bib20]). Similarly, transgenic transformation with wild-type *lat-1* or *lat-1::gfp* in-frame fusion transgenes rescues fertility demonstrating that *lat-1* is required for reproduction ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [Table S1](#mmc1){ref-type="supplementary-material"}).

We employed mating experiments and feminization mutants to identify the gamete type depending on *lat-1* function. In this instance, we observed that the ability to fertilize wild-type oocytes is reduced in *lat-1* mutant males (N2 male x *fem-1* hermaphrodite: 230 ± 8, n = 8; *lat-1(ok1465)* male x *fem-1* hermaphrodite: 193 ± 5, n = 8; p = 0.0012; [Figure 1](#fig1){ref-type="fig"}C). This indicates that in addition to defects in embryonic tissue polarity *lat-1* mutants show impaired sperm development or sperm function.

Thus, in addition to embryogenesis sperm function similarly depends on the presence of intact *lat-1* signals offering a second biological context for testing latrophilin activity using modified receptor variants. We have used two *lat-1* phenotypes---development and fertility---to systematically investigate the requirements of protein domains present in the LAT-1 receptor molecule via transgene complementation, and to delineate the contribution of these domains to the *lat-1* wild-type gene product's activity.

The HRM Is Not Required for Receptor Activity {#sec2.2}
---------------------------------------------

Previously we determined that transgenic rescue of *lat-1(ok1465)* absolutely requires the presence of the lectin-like RBL domain at the N terminus (ΔRBL and ΔTM2-7/ΔRBL; [Figures 2](#fig2){ref-type="fig"}A--2C and [Table S1](#mmc1){ref-type="supplementary-material"}) ([@bib38]; [@bib20]). The HRM has been suggested to act as a binding site for a putative secondary ligand in aGPCR signaling ([@bib18]), which would be consistent with its similarity to the ligand-binding domain of secretin-like GPCR ([Figures S1](#figs1){ref-type="fig"}B and S1C). Consequently we generated LAT-1 receptor variants with a modified HRM. Interestingly, activity ([Figure 2](#fig2){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}) and expression ([Figures 2](#fig2){ref-type="fig"}D, 2E, [S2](#figs2){ref-type="fig"}A, S2B, and [S3](#figs3){ref-type="fig"}B) of transgenes that lack the *lat-1* HRM (ΔHRM), or in which it is replaced by a divergent heterologous HRM from the nematode CELSR/Fmi homolog *cdh-6* (HRM^CDH-6^), is indistinguishable from wild-type constructs.

Molecular models of several HRM of B1/secretin-like GPCR that have recently been solved ([@bib14]; [@bib27]; [@bib31]) are consistent with the rescue data on the dispensable requirement of the HRM for receptor function. The models reveal a highly conserved domain core similar to the short consensus repeat (SCR fold, also known as Sushi or CCP module) ([@bib25]). Peptide-hormone ligands bind to pockets formed by an N-terminal α helix folding back onto this core. The binding is primarily mediated by hydrophobic patches in the SCR fold ([Figures 3](#fig3){ref-type="fig"}A and 3B) ([@bib14]; [@bib27]). The HRM of aGPCR lack the ligand-binding helix whereas the SCR core is conserved ([Figures 3](#fig3){ref-type="fig"}A and 3C). The first disulfide bond, which fixes the ligand-binding helix to the core, and the residues forming the ligand-binding pockets on the SCR are absent ([Figures 3](#fig3){ref-type="fig"}A and 3C). In contrast to secretin-like HRM, the N and C termini of the SCR fold are predicted to be located at opposing ends of the structure ([Figures 3](#fig3){ref-type="fig"}B and 3C), consistent with an extended conformation as described in non-HRM proteins ([@bib25]).

Molecular modeling thus strongly suggests that the HRM of aGPCR are SCR-like structural elements that lack the features required for the binding of peptide hormones by secretin receptor-like HRM ([@bib27]). We conclude that the HRM is dispensable for productive receptor activation and there is no evidence for an essential ligand-binding activity of the LAT-1 HRM.

LAT-1 Domains Relay Different Functions {#sec2.3}
---------------------------------------

We next tested the impact of the 7TM domain of LAT-1, which revealed 7TM-dependent and 7TM-independent components of the Lat phenotype. Transgenes carrying wild-type *lat-1* and *lat-1::gfp* fusions rescue lethality and fertility phenotypes in *lat-1(ok1465)* animals ([Figure 2](#fig2){ref-type="fig"}A and [Table S1](#mmc1){ref-type="supplementary-material"}). In contrast, constructs expressing truncated LAT-1 variants lacking the 7TM/C terminus module (ΔTM2-7) or the intracellular C-terminal domain (ΔC-term) retain activity to complement the fertilization defect in *lat-1* mutants, but did not rescue the tissue polarity phenotype ([Figure 2](#fig2){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}).

To rule out that 7TM-independent activity of the ΔTM2-7 receptor requires specific sequences in the first TM helix, we exchanged the remaining TM1 segment of the ΔTM2-7 receptor for a heterologous transmembrane anchor from the nematode integrin homolog *pat-3*. ΔTM2-7/TM^PAT-3^ exhibited no loss of activity compared to a ΔTM2-7 transgene ([Figure 2](#fig2){ref-type="fig"}C and [Table S1](#mmc1){ref-type="supplementary-material"}). In contrast, functionality of the ΔTM2-7 transgene was still absolutely dependent on the presence of the RBL domain (ΔTM2-7/ΔRBL; [Figure 2](#fig2){ref-type="fig"}C and [Table S1](#mmc1){ref-type="supplementary-material"}) ([@bib20]).

Three possible models could explain the 7TM-independent function of LAT-1. First, the ectodomain might act as a ligand for a reciprocal receptor on an adjacent cell to provide a "reverse signaling" function, as has been shown for Notch-Delta signaling ([@bib7]). Second, the split personality receptor model would suggest that the truncated constructs express an intact ectodomain, which is released by GPS cleavage and recombines with different 7TM domains to form an active receptor ([@bib33]). As a third alternative, the truncated constructs might identify a distinct "forward signaling" state of LAT-1 receptor complex that does not require 7TM domain activation, e.g., the interaction and association with a coreceptor on the LAT-1-expressing cell ([@bib10]; [@bib36]).

Proteolysis of the GPS Is Dispensable for LAT-1 Activity {#sec2.4}
--------------------------------------------------------

We investigated the 7TM-independent function of LAT-1 by mutagenesis of the GPS. The GPS is the most highly conserved feature of aGPCR ([Figures 1](#fig1){ref-type="fig"}A and [S1](#figs1){ref-type="fig"}B), and is invariably present proximal to the 7TM domain ([Figure S1](#figs1){ref-type="fig"}C). The polycystic kidney disease gene product Polycystin-1 (PKD1) belongs to the only other protein family containing a GPS; in this protein context the GPS is also positioned close to a transmembrane domain ([Figure S1](#figs1){ref-type="fig"}B). The autocatalytic cleavage activity of the GPS in different molecular contexts has been investigated in detail ([@bib21]; [@bib40]), and crystal structures revealed that the GPS motif is embedded within a larger GAIN (GPCR-autoproteolysis inducing) domain required and sufficient for GPS proteolysis ([@bib1]).

*C. elegans* LAT-1 and its paralog LAT-2 possess the HL↓(S/T) cleavage consensus sequence and are cleaved as predicted ([Figures 4](#fig4){ref-type="fig"}A and [S4](#figs4){ref-type="fig"}A). In a split personality receptor model, cleavage of LAT-1 molecules at the GPS is essential for activity by release of the ectodomain and re-association with other 7TM modules.

To probe whether GPS cleavage is required for LAT-1 signaling, we introduced mutations at positions −2 (GPS^H528A^) or +1 (GPS^T530A^) of the consensus motif, which abolish autocatalytic cleavage activity but retain cell surface expression ([@bib21]; [@bib42]). As expected, LAT-1 proteins containing either mutation were resistant to autocatalytic cleavage ([Figure 4](#fig4){ref-type="fig"}B) but were expressed normally ([Figures 4](#fig4){ref-type="fig"}C, [S2](#figs2){ref-type="fig"}C, and [S3](#figs3){ref-type="fig"}B). Surprisingly, the rescue of lethality and fertility phenotypes by cleavage-deficient full-length receptors is statistically not different from cleavable wild-type controls ([Figure 4](#fig4){ref-type="fig"}E and [Table S1](#mmc1){ref-type="supplementary-material"}).

These results are consistent with the observation that the consensus sequence for autocatalytic cleavage of aGPCR is frequently lost in evolution, as has occurred in the CELSR/Fmi, EMR, and BAI aGPCR subfamilies that constitute ∼50% of the aGPCR family ([Figures S1](#figs1){ref-type="fig"}A and [S4](#figs4){ref-type="fig"}B). Analysis of Ka/Ks ratios indicates persistent strong selective pressure on the GPS-coding regions even if the cleavage consensus is lost ([Table S2](#mmc2){ref-type="supplementary-material"}), strongly suggesting a cleavage-independent role of the GPS.

We next introduced noncleavable GPS modifications into the truncated ΔTM2-7 receptor context, showing that the 7TM-independent activity of LAT-1 does also not require GPS cleavage (GPS^H528A^/ΔTM2-7, GPS^T530A^/ΔTM2-7; [Figure 4](#fig4){ref-type="fig"}F and [Table S1](#mmc1){ref-type="supplementary-material"}). This is further supported by the fact that the truncated constructs display similar activities in *lat-1* single mutants and in *lat-1 lat-2* double mutants (data not shown). Together, these results indicate that the 7TM-independent function cannot be explained by a transfer of the LAT-1 N-terminal fragment (NTF) to the C-terminal fragment (CTF) of LAT-2 ([@bib39]; [@bib33]).

An Interaction between the GPS and 7TM Domains Is Required for LAT-1 Function {#sec2.5}
-----------------------------------------------------------------------------

Although autocatalytic cleavage is not absolutely required and conserved, the presence of the GPS immediately next to TM domains is highly specific for aGPCR and PKD1 ([Figures 1](#fig1){ref-type="fig"}A and [S1](#figs1){ref-type="fig"}B). A secreted version of the LAT-1 ectodomain (ΔTM1-7; [Figure 2](#fig2){ref-type="fig"}B) and in-frame deletions of the GPS are completely devoid of rescuing activity in both truncated (ΔGPS/TMΔ2-7) ([@bib20]) and full-length context (ΔGPS; [Figures 4](#fig4){ref-type="fig"}E, 4F, and [Table S1](#mmc1){ref-type="supplementary-material"}), whereas surface expression of ΔGPS is intact (data not shown). These results suggest that the GPS is essential for LAT-1 signaling. These findings argue against a reverse signaling model, as the presentation of the RBL domain on a shortened membrane-tethered ectodomain should be sufficient to supply rescue activity and the membrane-proximal GPS should not be required. A clinically relevant mutation inside the GPS of the GPR56 receptor (GPS^C497S^) is present in patients suffering from bilateral frontoparietal polymicrogyria (BFPP). This mutation changes an absolutely conserved cysteine residue, which is required for receptor maturation and cell surface expression ([@bib28]). We confirmed this in our transgenic assay by the introduction of an equivalent mutation in *lat-1* disrupting the predicted disulfide bond pattern of the GPS, which abrogated LAT-1 surface expression and resulted in an inactive receptor ([Figure 4](#fig4){ref-type="fig"}E). Thus, the inactivity of the ΔGPS constructs is due to a sequence-specific requirement for the LAT-1 GPS.

To test for a sequence-specific requirement of the LAT-1 GPS, we constructed chimeric receptors in which the LAT-1 GPS was exchanged for the GPS of *C. elegans* LAT-2 (GPS^LAT-2^; GPS^LAT-2^/ΔTM2-7). The primary sequence of the LAT-2 GPS is similar in length and is 50% identical in amino acid sequence to the LAT-1 GPS. It retains the positions and intramolecular distances of all key structural elements ([Figure S4](#figs4){ref-type="fig"}A). The chimeric constructs undergo autocatalytic cleavage (data not shown) and show normal expression on the cell surface ([Figures 4](#fig4){ref-type="fig"}D, [S2](#figs2){ref-type="fig"}D, and [S3](#figs3){ref-type="fig"}B). Surprisingly, the full-length GPS^LAT-2^ receptor chimera rescues the fertilization defect of *lat-1(ok1465)* mutants but has no activity in tissue polarity signaling ([Figure 4](#fig4){ref-type="fig"}E and [Table S1](#mmc1){ref-type="supplementary-material"}), a profile indistinguishable from constructs lacking an active 7TM domain ([Figure 2](#fig2){ref-type="fig"}B and [Table S1](#mmc1){ref-type="supplementary-material"}). In contrast, the truncated chimeric construct GPS^LAT-2^/ΔTM2-7 shows no residual activity ([Figure 4](#fig4){ref-type="fig"}E and [Table S1](#mmc1){ref-type="supplementary-material"}).

This indicates that a sequence-specific function of the GPS other than autocatalytic cleavage or surface expression is required for the 7TM-dependent and 7TM-independent activities of LAT-1.

Cross-Activation of LAT-1 Receptors {#sec2.6}
-----------------------------------

All findings regarding the different LAT-1 receptor variants are consistent with a model in which the 7TM-independent function is mediated by the localization of LAT-1 in a presignaling complex, which can be mediated by either the 7TM or the GPS. The full receptor function requires the presence of a matching pair of GPS and 7TM domains, for example by the GPS acting as a tethered endogenous ligand for the 7TM domain.

To test this model, we investigated whether a pair of mutant transgenes expressing different receptor variants each lacking the 7TM function can reconstitute full receptor activity by intermolecular complementation ([@bib30]). In this assay, the truncated ΔTM2-7 construct provides the wild-type N terminus and GPS, whereas the GPS^LAT-2^ construct harboring a mutant N terminus contributes a wild-type but inactive 7TM/C terminus module. Coinjection of the transgenes ΔTM2-7 and GPS^LAT-2^, which individually only rescue the fertility defect but not lethality to wild-type level, fully reconstitutes LAT-1 activity for both requirements ([Figure 5](#fig5){ref-type="fig"}A and [Table S1](#mmc1){ref-type="supplementary-material"}). We excluded that DNA recombination between the transgenes accounted for the intermolecular complementation as we were unable to detect repaired constructs by PCR in rescued strains.

We also observed that the intermolecular complementation of LAT-1 function is not dependent on GPS cleavage, as a GPS cleavage mutation on the "donor" (ΔTM2-7/GPS^T530A^) or the "recipient" (GPS^LAT-2(T874A)^) side does not prevent productive complementation ([Figure 5](#fig5){ref-type="fig"}A and [Table S1](#mmc1){ref-type="supplementary-material"}). The fact that the recipient construct can be cleavage-deficient strongly argues against the reconstitution of active monomers by transfer of N termini to 7TM domains in a split personality receptor scenario, as in our assay the inactive N terminus at the recipient receptor was inaccessible for replacement through lack of GPS cleavage.

However, both donor and recipient require the presence of the RBL domain, as the ΔTM2-7 construct does not complement the ΔRBL mutant that contains a wild-type GPS and 7TM ([Figure 5](#fig5){ref-type="fig"}A). This suggests that ligand-induced proximity of two LAT-1 receptors mediated by the RBL domain might be required for the intermolecular complementation of GPS and 7TM domains. Our results are consistent with a model in which the ligand-induced dimerization of the NTF leads to the cross-activation of the 7TM domain by the GPS of the partner molecule. To further test this dimerization/activation model, we performed biochemical studies of the LAT-1 ectodomain expressed in HEK293 cells. Gel filtration and analytical ultracentrifugation of supernatants from cells expressing an epitope-tagged LAT-1 ectodomain show that the LAT-1 ectodomain is present in both monomeric and dimeric form ([Figure 5](#fig5){ref-type="fig"}B). The dimeric form is very stable in low protein concentrations, but is not mediated by covalent bonds ([Figure 5](#fig5){ref-type="fig"}C). These data are consistent with the prediction that the LAT-1 ectodomains can form stable dimers.

*lat-1* and *ten-1*/Teneurin Are Expressed on the Same Cells and Are Not Epistatic {#sec2.7}
----------------------------------------------------------------------------------

Although the ability for intermolecular complementation sheds light on the 7TM-dependent activity of LAT-1, it does not account for the 7TM-independent function of the receptor. Such function might require interaction with an additional molecule(s) to yield co-reception and/or co-signaling similar to the association of the aGPCR *Fmi/Stan* of *Drosophila melanogaster* with the transmembrane proteins *Frizzled* (*Fz*) and *Van Gogh/Strabismus* (*Vang/Stbm*) ([@bib10]; [@bib36]).

In a recent biochemical screen Teneurin-2/Lasso/Neurestin/DOC4/Tenascin-m was identified as a potential ligand for the Latrophilin-1 ([@bib34]). The *C. elegans* genome contains only a single teneurin homolog, *ten-1*. Animals carrying the null allele *ten-1(ok641)* exhibit morphogenesis defects ([@bib11]) phenocopying defects observed in *lat-1(ok1465)* embryos. Consequently, we sought to confirm whether *lat-1* and *ten-1* function as receptor-ligand pair in vivo by investigating the genetic relationship between the null alleles *lat-1(ok1465)* and *ten-1(ok641)* on the basis of their individual and combined effects on development and fertility ([@bib20]).

Interestingly, *lat-1; ten-1* double mutants exhibited almost completely penetrant developmental arrest and a greatly reduced brood size ([Figures 6](#fig6){ref-type="fig"}A, 6B and [Table S3](#mmc3){ref-type="supplementary-material"}). We further observed that *lat-1* and *ten-1* alleles displayed nonallelic noncomplementation as animals carrying at least one wild-type allele for both loci already exhibited significant defects in embryogenesis and fertility ([Figures 6](#fig6){ref-type="fig"}A, 6B and [Table S4](#mmc4){ref-type="supplementary-material"}). This dosage-sensitivity indicates that both genes are acting at least partly in parallel during development and germline function and implies a synergistic rather than linear interaction between both genes. Although the devastating condition of the *lat-1; ten-1* double mutants precluded the introduction of the ΔTM2-7 receptor as a direct test of whether the 7TM-independent activity of LAT-1 requires presence of TEN-1, our genetic data are consistent with a model where both proteins function as coreceptors for a yet unknown ligand relaying nonidentical signaling outputs into the same cell.

To corroborate this model we studied the expression patterns of *lat-1* and *ten-1* using transcriptional reporter transgenes. We have previously noted that an integrated *lat-1::gfp* transcriptional reporter transgene is expressed during epidermal dorsal intercalation of the epidermis, specifically only in left epidermoblasts ([@bib20]). This results in a highly reproducible zebra-like pattern on the dorsal epidermis prior to syncytial fusion of these cells. In contrast, both nonsuperficial neuroblasts and right intercalating epidermoblasts are devoid of *lat-1::gfp* expression. Using 4D microscopy we mapped *lat-1* expression to ABplaaaap daughters, ABarppaapa, and all four Caaa granddaughters ([Figures 6](#fig6){ref-type="fig"}C and 6E). Intriguingly, an independently expressed *ten-1a::gfp* promoter reporter ([@bib23]) shows expression in the same epidermal blastomeres as *lat-1::gfp* ([Figures 6](#fig6){ref-type="fig"}D and 6E) and additional lineages (ABaraax, MSapx, MSppx; data not shown) except one (Cpaaaa; [Figures 6](#fig6){ref-type="fig"}D and 6E). This implies that *lat-1* and *ten-1* act on the same cell rather than in *trans* to each other.

Taken together these results suggest that *lat-1* and *ten-1* have overlapping but not identical functions during embryonic morphogenesis and fertility, and are unlikely to act linearly as receptor and ligand in *C. elegans*.

Discussion {#sec3}
==========

The biological effects of aGPCR activation are involved in complex cellular traits such as developmental decisions. Thus, the limiting factor for the study of this receptor class has been the availability of informative assays. To overcome this difficulty, we have developed an in vivo assay based on the transgenic complementation of *lat-1(ok1465)*, a developmentally lethal and subfertile *lat-1* mutant strain. This assay evaluates the activity of engineered receptor variants (summarized in [Figure 7](#fig7){ref-type="fig"}A) interacting with wild-type up- and downstream components of the pathway irrespective of prior knowledge on their identity.

Our observations indicate that the HRM of LAT-1 is dispensable for receptor function in our assays. We find no evidence for a specific ligand-binding function of the LAT-1 HRM by domain deletion (ΔHRM) or domain exchange (HRM^CDH-6^) experiments. This result is in apparent contradiction to similar receptor mutants of the *Drosophila* aGPCR FMI, where deletion of the HRM (FMI^ΔHRM^) resulted in loss of receptor activity ([@bib18]). However, this has been interpreted as the result of a nonspecific change of domain geometry in FMI^ΔHRM^ leading to a total loss of FMI function rather than a specific loss of a putative HRM ligand binding activity. In addition, molecular models based on the 3D structures of the HRM of B1/secretin-like GPCR of the GLP receptor group show that features crucial for ligand binding are not conserved in aGPCR, although hormone binding to secretin-type HRM might differ. In contrast, we find conservation of the SCR-like fold in both 7TM families suggesting that it is a structural component of the evolutionarily ancient aGPCR family, "shuffled" into the proximity of the 7TM domain and acquired ligand binding features in B1/secretin-like GPCR ([@bib24]).

We further demonstrate that proteolysis at the GPS of LAT-1 is not necessary for receptor trafficking and activity in vivo. Previously, autoproteolytic function of the GPS, the common molecular denominator of all aGPCR class members ([@bib4]), has been a central element in models of aGPCR maturation and signaling ([@bib26]; [@bib22]). Our findings are consistent with recent pharmacological data that show intact signaling capacity of the human aGPCR GPR133 carrying similar cleavage-disrupting mutations ([@bib5]). In addition, the results are also in accord with the presence of cleaved and uncleaved forms of  aGPCR on the plasma membrane of native tissue ([@bib17]), and with data suggesting that surface expression of aGPCR can occur independently of GPS cleavage ([@bib9]; [@bib21]; [@bib19]).

In contrast to GPS proteolysis, we observe that aGPCR signaling requires presence of a GPS as a structural element. The central finding underpinning this notion is the loss of activity in a receptor chimera carrying a heterologous GPS domain of LAT-2 in a LAT-1 context (GPS^LAT-2^) during development. A similar effect is achieved if the 7TM domain of LAT-1 is truncated but the GPS is left intact (ΔTM2-7). This suggests that the GPS interacts with the homologous 7TM domain of LAT-1, and possibly serves as an endogenous ligand during receptor activity. We investigated this model by intermolecular complementation assays using pairs of signaling-deficient LAT-1 variants. A combination of GPS^LAT-2^ and ΔTM2-7 receptors, each deficient in rescuing developmental defects of *lat-1* mutants, reconstitutes full receptor function. This implies that homologous pairing of GPS and 7TM from two receptor molecules is required for receptor activity, which is corroborated by our biochemical evidence of LAT-1 dimers. Recent structural data of the GAIN domain, in which the GPS motif is embedded, will help to guide site-directed mutagenesis efforts to probe this putative interface in the future ([@bib1]).We also provide evidence that the split personality model of aGPCR activity ([@bib33]) does not account for reconstituted receptor function of hemi-receptors in the in vivo complementation assay. The biological implications of this split personality receptor model are intriguing as the putative cross-interaction of NTF and CTF derived from different aGPCR precursors could potentially re-route external signals perceived via the NTF to alternative intracellular messenger cascades activated through the CTF. The model suggests that the GPS^LAT-2^-ΔTM2-7 reconstitution could ensue through formation of a functional receptor chimera by transfer of the NTF donated by the ΔTM2-7 to the CTF of the GPS^LAT-2^ after GPS cleavage of both parent receptors ([@bib33]). Interestingly, we find that proteolysis-deficient receptor versions of either partner are sufficient to reconstitute full function in vivo. Consequently, it appears unlikely that aGPCR signaling requires domain exchange in accord with a split personality model.

The GPS^LAT-2^ chimeric receptor also uncovered separate effects of *lat-1* on fertility and tissue polarity/morphogenesis. *lat-1* is expressed in the somatic gonad ([@bib20]), and *lat-1* mutants show reduced number of eggs laid and a high degree of sterility. Loss of fertility in *lat-1* mutants but not developmental defects are efficiently rescued by a chimeric GPS^LAT-2^ receptor. This suggests that two different activities reside in the LAT-1 receptor molecule. One requires an interaction with the 7TM domain (LAT-1^GPS^ ↔ LAT-1^7TM/C^) constituting a forward signal triggered by the GPS as a tethered agonist and transduced by the 7TM. The second activity is independent of the 7TM domain (LAT-1^GPS^ ↔ X). Thus, the GPS interacts with partners, which are differentially affected in the chimeric GPS^LAT-2^ receptor protein. Two different models can be devised to account for the 7TM-independent function of LAT-1.

In the bidirectional signaling model a second, reverse signal is transmitted to the partner cell via engagement of the RBL domain ([Figure 7](#fig7){ref-type="fig"}B). The forward signal is disrupted in the GPS^LAT-2^ chimera, whereas the reverse signal is still present. Studies in *Drosophila* suggest that another aGPCR design, the CELSR homolog FMI/STAN, also relays bidirectional signaling states via heterologous *cis*-interactions (forward signal) ([@bib37]; [@bib10]; [@bib36]) and homophilic *trans*-interactions (reverse signal) ([@bib37]; [@bib18]; [@bib10]). Our molecular analyses do not support a noncell-autonomous activity of a diffusible LAT-1 ectodomain ([@bib20]), a separable activity of the anchored N terminus based on adhesive properties, or the activation of counter-receptors on adjacent cells in a reverse signaling mode (this work). We do not observe partial rescue through a receptor lacking the GPS (ΔGPS), where the reverse signal should still be intact. But we can currently not exclude that the overall topology of the receptor is disrupted in ΔGPS nor can we exclude that N-terminal portions of the GAIN domain, the interspaced region between HRM and GPS ([@bib1]), contributes to reverse signal.

The alternative bimodal forward signaling model encompasses a second, parallel forward signal that is still active in the GPS^LAT-2^ chimera ([Figure 7](#fig7){ref-type="fig"}C). Our results are consistent with a model in which the homodimerization of the NTF could be ligand-induced through the RBL domain. This would lead to the cross-activation of the 7TM domain by the GPS of the partner molecule ([Figure 7](#fig7){ref-type="fig"}). The model is consistent with the action of the GPS as a tethered agonist of the 7TM domain (forward signal 1) and mediating protein-protein interaction with accessory proteins equivalent to RAMPs in B1/Secretin-type GPCR (forward signal 2) ([@bib29]). An interaction candidate acting on the same cell membrane transducing the 7TM-independent activity of LAT-1, is Teneurin/*ten-1*, a putative LPHN1 ligand ([@bib34]). Our experiments show coexpression of *lat-1* and *ten-1* in the developing epidermis implying that LAT-1 and TEN-1 reside in close proximity in the cell membrane, possibly as part of the same signaling complex. In addition, animals lacking *lat-1* or *ten-1* display dosage-dependent nonallelic noncomplementation. These results are not compatible with an epistatic genetic relationship expected from a ligand-receptor pair but rather indicate parallel functions for *lat-1* and *ten-1*.

Finally, future studies need to focus on the possibility that features of both signaling models are present in aGPCR. Although we have found no direct evidence for a *trans*-acting function of LAT-1 in *C. elegans*, a recent report indicates that rodent Latrophilin 1/CIRL1/CL1 interacts in *trans* with neurexins/NRX with high affinity in cell culture ([@bib6]). This interaction requires the presence of the olfactomedin domain, which is only present in vertebrate latrophilin homologs ([Figure S1](#figs1){ref-type="fig"}B; [@bib20]), and might exert a role in synapse formation and/or function.

In summary, we have shown that the aGPCR LAT-1 is capable of relaying at least two different signals. The GPS comprises the central structural element of aGPCR function that could be instrumental for the conversion of an adhesive event into receptor output through G protein signaling, whereas the proteolytic nature of the GPS is not required for this activity. Given the general pharmacological tractability of 7TM receptors, aGPCR are an attractive yet unexploited target to modulate adhesion-triggered cell behaviors involved in neurological and immune functions, and for tumor treatment.

Experimental Procedures {#sec4}
=======================

*C. elegans* Strains {#sec4.1}
--------------------

*C. elegans* strains were cultured and manipulated according to standard protocols ([@bib8]). Wild-type worms were *C. elegans* variety Bristol, N2. Alleles *lat-1(ok1465)* and *ten-1(ok641)* were generated by the *C. elegans* gene knockout consortium. Strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). A full list of transgenic worm strains is included in the [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}.

Lethality and Fertility Rescue Assay {#sec4.2}
------------------------------------

The adult brood size and oocyte assay was conducted as previously described ([@bib20]). All experiments were conducted at least in triplicate. A two-tailed Mann-Whitney test of data sets against a respective wild-type control construct data set were performed using Prism 5 (GraphPad Software, La Jolla, CA).

Microscopy {#sec4.3}
----------

For analysis of transgene expression embryos were dissected from gravid hermaphrodites and mounted in M9 onto a 2% agarose pad. Images were acquired with a Deltavision Core (Applied Precision), a Leica SP5 II confocal microscope (Leica, Milton Keynes, UK) and a Zeiss confocal LSM5 setup. Four-dimensional imaging and lineage analysis of *lat-1::gfp* and *ten-1a::gfp* expressing cells were performed as previously described using SIMI Biocell software (SIMI Reality Motion Systems, Germany) ([@bib3]; [@bib20]). Z-stacks with spatial spacing of 0.5 μm were taken.

Protein Biochemistry {#sec4.4}
--------------------

Worms were washed off culture plates with ice-cold water, pelleted by centrifugation at 13,000 rpm for 5 min and freeze-cracked in dry ice/ethanol. The lysate was boiled in 100 μl TBS (20 mM Tris, 150 mM NaCl, pH 7.5) with 1% SDS for 10 min, spun down, and supernatant and pellet separately mixed with 2× Laemmli buffer. A detailed description of methodologies used for protein analysis including western blotting, immobilized metal ion affinity chromatography, size-exclusion chromatography by gel filtration, and analytical ultracentrifugation can be found in the [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}.

Extended Experimental ProceduresGeneration of Transgenic LinesAll transgenic strains with stably transmitting extrachromosomal arrays except the *ten-1a::gfp* reporter were generated by DNA microinjection as described ([@bib51]; [@bib50]). Cosmids were injected at a concentration of 1 ng/μl together with the coinjection marker *pRF4\[rol-6(su1006)+\]* (100 ng/μl) and *pBluescript II SK+* vector DNA (Stratagene, La Jolla, USA) as stuffer DNA to achieve a final concentration of 120 ng/μl. For coinjections of two different cosmids, 1 ng of each was utilized and the stuffer DNA adjusted accordingly. DNA was injected into the syncytical gonad of *lat-1(ok1465)/mIn1\[mIs14 dpy-10(e128)\]* hermaphrodites. Transgenic progeny were isolated and stable lines selected. Multiple independent transgenic lines were established for each transgene tested. A construct was scored as not rescuing when ten independent lines did not produce transgenic homozygotes. The *ten-1a::gfp* reporter construct *pQC08.3* ([@bib23]) together with the co-transformation marker *pBx\[pha-1+\]* was transformed biolistically into *pha-1(e2123ts)* mutants and transgenic worms were selected based on *pha-1* rescue at the restrictive temperature ([@bib58]). For detailed description of transgene construction see below.*C. elegans* Strains Used in the StudyThe following extrachromosomal arrays were created for this study: *aprEx47\[lat-1(1-581) (pTL20) rol-6(su1006) pBSK\], aprEx52\[lat-1(H528A) (pSP18) rol-6(su1006) pBSK\], aprEx53\[lat-1(H528A) (pSP18) rol-6(su1006) pBSK\], aprEx63\[lat-1(1-581; H528A) (pSP20) rol-6(su1006) pBSK\], aprEx69\[lat-1(T530A) (pSP19) rol-6(su1006) pBSK\], aprEx73\[lat-1(T530A) (pSP19) rol-6(su1006) pBSK\], aprEx84\[lat-1(1-581; T530A) (pSP30) rol-6(su1006) pBSK\], aprEx118\[lat-1ΔGPS(483-542)::gfp (pSP43) rol-6(su1006) pBSK\], aprEx130\[lat-1(C497S)::gfp (pSP44) rol-6(su1006) pBSK\], aprEx146\[lat-1ΔHRM(179-243)::gfp (pSP68) rol-6(su1006) pBSK\], aprEx147\[lat-1ΔHRM(179-243)::gfp (pSP68) rol-6(su1006) pBSK\], aprEx153\[lat-1(H528A)::gfp (pSP53) rol-6(su1006) pBSK\], aprEx157\[lat-1(lat-2 GPS) (pSP75) rol-6(su1006) pBSK\], aprEx158\[lat-1(lat-2 GPS) (pSP75) rol-6(su1006) pBSK\], aprEx159\[lat-1(cdh-6 HRM)::gfp (pSP79) rol-6(su1006) pBSK\], aprEx160\[lat-1(cdh-6 HRM)::gfp (pSP79) rol-6(su1006) pBSK\], aprEx166\[lat-1(T530A)::gfp (pSP85) rol-6(su1006) pBSK\], aprEx174-177 \[ten-1a::gfp pha-1(+)\].* The following alleles and transgenes have been previously described ([@bib20]): *qaEx7513\[lat-1(+) (pTL2) rol-6(su1006)\], aprEx77\[lat-1::gfp (pSP5) rol-6(su1006) pBSK\], aprEx89\[lat-1 (1-581)ΔGPS(483-542)::gfp (pSP36) rol-6(su1006) pBSK\], qaIs7524\[lat-1p::gfp (pTL13) rol-6(su1006)\].*Construction of TransgenesFor generation of constructs recombineering was employed ([@bib44]; [@bib56]) and accompanying protocols were modified to construct latrophilin transgenes using cosmids, PCR-amplified targeting cassettes, and positive antibiotic selection.Constructs pTL2 and pSP5 ([@bib20]) were used as a basis to construct modified versions with the recombination-competent *E. coli* strain SW105 developed by Copeland and co-workers ([@bib57]) (<http://recombineering.ncifcrf.gov/>) containing the genes of the λ-Red recombinase system under the control of a temperature-sensitive repressor that restricts recombination activity under normal growth conditions at 32°C. To induce recombinase expression, culture temperature was increased to 42°C for 15 min before making the bacteria electrocompetent for transformation.The cosmid to be modified was transformed into one of the strains, the recombinase system was induced and the bacteria were made electrocompetent again. Modification of the cosmid was conducted via a targeting cassette containing the desired modification and a kanamycin-resistance gene (*kanR*) under a prokaryotic promoter as a selection marker. These two were flanked by at least 40 bp of homology to the region where the cosmid should be modified. This targeting cassette was generated using different approaches depending on the modification, and then transformed into the electrocompetent bacteria containing the cosmid in which the recombination occurred. Cells with recombined cosmids were kanamycin-resistant and were selected on LB agar with kanamycin and grown in LB culture shaking at 32°C overnight. Cosmids were verified by restriction digest and sequencing.lat-1(179-243)::gfp (pSP68) = ΔHRMTo generate the deletion targeting cassette a *loxP-kanR-loxP* cassette was amplified from vector PL452 ([@bib49]) with primers lat1_282F/lat1_283R (for primer sequences see [Table S4](#mmc4){ref-type="supplementary-material"}) introducing at the 3′ end via the primer a sequence homologous to the last 10 bases of intron 4 and to exon 5 until the HRM of *lat-1*. A 341 bp fragment of the region downstream of the HRM was amplified using primers lat1_284F/lat1_285R and ligated to the also gel-purified *loxP-kanR-loxP* cassette. To ensure ligation of this fragment 5′ of the cassette, the forward primer of this fragment and the reverse primer of the cassette were phosphorylated beforehand. Ligation was conducted using an 1: 1 molar ratio of both fragments. 2 μl of the ligation product were used in a PCR amplifying the complete ligated fragment applying primers rec_138F/lat1_285R with overhangs homologous to pSP5. The resulting cassette was recombineered into pSP5 and the selection cassette subsequently removed.lat-1(cdh-6 HRM)::gfp (pSP79) = HRM^CDH-6^Construct pSP79 is based on pSP5. The targeting cassette consisted of two parts. *A loxP-kanR-loxP* cassette was amplified from vector PL452 using primers lat1_282F/lat1_283R introducing at the 3′ end via the forward primer a sequence homologous to the last 10 bases of intron 4 and to exon 5 until the HRM of *lat-1*. The HRM of *cdh-6* (aa 1913 - 1975) was amplified using primers lat1_327F/lat1_328R from a *C. elegans* cDNA library. The reverse primer of the *loxP-kanR-loxP* cassette and the forward primer of the *cdh-6* HRM were phosphorylated beforehand. Both fragments were ligated using an 1: 1 molar ratio. 2 μl of the ligation product were used in a PCR amplifying the complete ligated fragment applying primers rec_138F/rec_141R containing overhangs homologous to pSP5, the PCR product gel-purified and recombineered into pSP5. The selection cassette subsequently removed.lat-1(1-581; pat-3 TM) (pSP38) = TMΔ2-7/TM^PAT-3^Replacement of the first transmembrane domain of LAT-1 with the one of the β-integrin PAT-3 (GenBank acc. no. Z35604.2 GI:19571719) was performed using a two-step strategy. A sequence of *pat-3* corresponding to aa 738 -- 760 (bp 2214 -- 2280) was synthesized by Geneart (Berlin, Germany) together with the sequence upstream the first transmembrane domain corresponding to aa 509 -- 549 (bp 1527 -- 1647) 5′ of the *pat-3* sequence. Synthesis product and the vector pPolycistronic were cut with *Age*I and *Nco*I, gel-purified, ligated and transformed into chemically competent *E. coli* TOP10 cells. The subcloned fragment, the *gfp* and the *kanR* cassette from pPolycistronic were amplified with primers lat1_216F/lat1_217R with the reverse primer containing a homologous sequence to the 3′ UTR of *lat-1*, gel-purified and recombineered into pTL2.lat-1(37-542, T530A) (pSP32) = LAT-1(37-542)^GPS(T530A)^::6xHisThe *lat-1* GPS and N-terminus sequences were amplified from *C. elegans* cDNA using primers lat1_190F/lat1_191R. Forward primers contained an *Age*I site and reverse primers a KpnI site and the GPS T530A mutation changing codon ACA to GCA. Fragments were gel-purified, digested with *Age*I and KpnI, purified using a QIAquick PCR purification kit and ligated into the vector pHLSeq, which was also cut with *Age*I and KpnI and gel-purified. The ligation mix was transformed into chemically competent *E. coli* TOP10 cells (Invitrogen, Paisley, UK) according to manufacturer\'s instructions.lat-1(C497S)::gfp (pSP44) = GPS^C\ \>\ S^To generate the point mutation targeting cassette for pSP44, a 450 bp fragment of exon 5 was amplified from pTL2 using primers lat1_03F/lat1_218R introducing to codon change TGT \> AGT with the reverse primer. The selection-cassette was amplified together with 0.7 kb of exon 5 upstream of the cassette from pSP34 using primers lat1_219F lat1_220R (intermediate cosmid with *FRT-kanR-FRT* \[not shown\]). Reverse primer of the first and forward of the latter were phosphorylated beforehand. Both fragments were ligated using an 1:1 molar ratio. 3 μl of the ligation product were used in a PCR amplifying the complete ligated fragment applying primers lat1_03F/lat1_220R with overhangs homologous to pSP5, the PCR product was transformed in electrocompetent, recombinase-induced SW105 cells containing pSP5 for recombineering. The resulting cassette was recombineered into pSP5 and the selection cassette subsequently removed.lat-1(H528A) (pSP18) = GPS^H\ \>\ A^, lat-1(T530A) (pSP19) = GPS^T\ \>\ A^, lat-1(H528A)::gfp::lat-1 (pSP53) = GPS^H\ \>\ A^, lat-1(T530A)::gfp::lat-1 (pSP85) = GPS^T\ \>\ A^Cosmids pSP53 and pSP85 are based on pSP5, cosmids pSP18 and pSP19 are based on pTL2. The targeting cassette consisted of two parts. A 0.2 kb fragment of exon 5 was amplified from pTL2 with forward primers introducing a point mutation. For H528A the codon CAT was changed to GCT (primers lat1_150F/lat1_149R), for T530A the codon ACA was changed to GCA (primers lat1_148F/lat1_149R). The reverse primer contained an overhanging *Hind*III site. The second part of the cassette was the *FRT-kanR-FRT* cassette amplified from pIGCN21 ([@bib59]) (primers lat1_137F/lat1_138R) with the forward primer containing an overhanging HindIII site. Both fragments were, cut with *Hind*III and ligated using an 1: 1 molar ratio. 2 μl of the ligation product were used in a PCR amplifying the complete fragment applying primers rec_97F/rec_96R or rec_95F/rec_96R with overhangs homologous to pSP5/pTL2. The resulting cassettes were recombineered into pSP5/pTL2 and the selection cassettes subsequently removed.lat-1(1-581;H528A)::gfp (pSP20) = GPS^H\ \>\ A^/ΔTM2-7, lat-1(1-581;T530A)::gfp (pSP30) = GPS^T\ \>\ A^/ΔTM2-7Cosmids pSP20 and pSP30 are based on pTL20 and generated by using the same strategy ([@bib20]). A 4.2 kb BamHI-fragment was released from pTL20 containing exon 4, exon 5 and the *gfp::kan* cassette as well as the 3′UTR of *lat-1*. This fragment was gel-purified and used as a targeting cassette for recombineering into the corresponding full length construct: into pSP18 to generate pSP20 and into pSP19 to generate pSP30.lat-1(483-542)::gfp (pSP43) = ΔGPSThe targeting cassette deleting the sequence corresponding to aa 483 -- 542 of LAT-1 was generated by fusion of two fragments. First, a 421 bp fragment containing the sequence 5′ of the GPS was amplified from pTL2 (primers lat1_212F/lat1_213R \[phosphorylated\]). Second, the sequence 3′ of the GPS followed by the selection-cassette in intron 5 was amplified from pSP34 (intermediate with *FRT-kanR-FRT*, not shown) with primers lat1_214F (phosphorylated)/lat1_221R. Both fragments were ligated using an 1:1 molar ratio. 3 μl of the ligation product were used in a PCR amplifying the complete ligated fragment applying primers with overhangs homologous to pSP5 (lat1_212F/lat1_221R). The resulting cassette was recombineered into pSP5 and the selection cassette subsequently removed.lat-1(lat-2 GPS)::gfp (pSP75) = GPS^LAT-2^In cosmid pSP75, the LAT-1 GPS (aa 483-542) is exchanged for the LAT-2 GPS (aa 837-886). The *lat-2* GPS was amplified from a *C. elegans* cDNA library using primers lat1_247F/lat1_248R, the selection cassette was amplified from pSP34 (intermediate with *FRT-kanR-FRT* (not shown)) using primers lat1_244F/lat1_246R for recombineering into pSP5. The reverse primer of the first and forward primer of the second fragment were phosphorylated. Both fragments were ligated using an 1:1 molar ratio. 3 μl of the ligation product were used in a PCR amplifying over the complete length of the ligation product using primers rec_135F/rec_136R for recombineering into pSP5. The selection cassette subsequently removed.lat-1(1-795)::gfp (pSP21) = ΔCtermTo yield construct pSP21, the *gfp::kanR* cassette of cosmid pTL20 was amplified using primers rec_102F/rec_103 inserting five alanines with the forward primer. Fragments were gel-purified and transformed into electrocompetent SW105 cells for recombineering.lat-1(lat-2 GPS^T530A^)::gfp::lat-1 (pSP97) = LAT-2^GPS(T\ \>\ A)^This cosmid is based on pSP75. The targeting cassette consisted of two parts. A 0.2 kb fragment around the GPS was amplified from pSP75 (primers lat1_335F/lat1_336R) with the forward primer introducing a point mutation. The codon ACA was changed to GCA. The reverse primer contained an overhanging *Hind*III site. The second part of the cassette was the *loxP-kanR-loxP* amplified from vector PL452 (primers lat1_337F/lat1_338R) with the forward primer containing an overhanging *Hind*III site. Both fragments were cut with *Hind*III and ligated. The ligation product were used in a PCR amplifying the complete fragment applying primers with overhangs homologous to pSP75 (lat1_335F/lat1_338R). The PCR product was gel-purified and recombineered into pSP75. The selection cassette subsequently removed.Normalization of Data Sets for Rescue and Epistatic InteractionLethality rescue$$\overline{xn} = \frac{1}{n}\sum\limits_{i = 1}^{n}{xn_{i}}$$where$$xn = \frac{xr - m_{lat - 1{({ok1465})}}}{m_{lat - 1{( + )}}}$$where*xn* is the normalized value,*xr* is the raw value,*m*~*lat-1(ok1465)*~ is the mean of the *lat-1(-)* mutant population,*m*~*lat-1(+)*~ is the mean of the population injected with the corresponding wild-type construct.Fertility rescue$$\overline{xn} = \frac{1}{n}\sum\limits_{i = 1}^{n}{xn_{i}}$$where$$xn = \frac{xr}{m_{lat - 1{( + )}}}$$where*xn* is the normalized value,*xr* is the raw value,*m*~*lat-1(+)*~ is the mean of the population injected with the corresponding wild-type construct.FM4-64 CostainingPlasma membrane co-staining of transgenic worm strains carrying LAT-1::GFP variants was performed using the styryl dye FM4-64 ([@bib61]; [@bib59]). Adult transgenic worms were incubated in 10 mM NaN~3~ for 15 min and cut after the pharyngeal-intestinal valve with two 27 gauge syringe needles. Anterior worm halves containing the pharynx and the nerve ring were then immersed for 5 min in dying solution containing 10 μg/ml FM4-64 (Cat. no. T3166; Molecular Probes, Eugene, USA) in Dent's saline, washed once for 5 min in Dent's saline and mounted on 1% agar pads. Two channel confocal image stacks with a *z* spacing of 1 μm of the pharynx and nerve ring were collected with an inverted Zeiss LSM510 confocal microscope with a Plan-Apochromat x63/ 1.4 oil immersion DIC objective and a 2x digital zoom, using the 488 nm argon and 543 nm helium-neon laser lines for excitation of GFP and FM4-64, respectively. Similar laser intensities (488 nm: 36%; 543 nm: 45%), pinhole size (optical slice thickness: 1 μm) and gain settings were used for all specimens. All images were saved as 512x512 pixel-images at 8 bit resolution.Signal intensity in an image region outside the specimen was determined for each channel of the stacks and subtracted from the entire image intensity using ImageJ to correct for background signal. FM4-64 data were false-colored in magenta the render the images accessible for red-green color-blind readers.Quantitative Colocalization of GFP/FM4-64 Signals via Intensity Correlation AnalysisQuantification of spatial overlay of signals in both channels of LAT-1::GFP/FM4-64 stacks were analyzed with the intensity correlation method developed by Stanley and colleagues as described in ([@bib47]) using the WCIF ImageJ bundle software v1.37a (University Health Network Research, Toronto, Canada; <http://www.uhnresearch.ca/facilities/wcif/fdownload.html>). In brief, ROI in a selected plane from non-saturated GFP/FM4-64 confocal image stacks corrected for the mean background staining (see above) of each rescuing LAT-1::GFP variant were analyzed using the 'Intensity correlation analysis' ImageJ plugin. To render the spatial relationship of GFP and FM4-64 signals in individuals within and between different transgenic worms strains comparable, FM4-64 staining and embedding was performed for all strains under identical conditions, and similar cellular profiles in the terminal bulb were selected for colocalization analyses. Intensity correlation quotients (ICQ) were calculated for each individual ROI. ICQ values reflect whether staining intensities are associated in segregated (−0.5 \< ICQ ≤ 0), random (ICQ = ∼0) or dependent (0.5 ≥ ICQ \> 0) manner. Statistical analysis of ICQ values via a two-tailed Mann-Whitney test was performed with Prism 5.0a (GraphPad Software Inc., San Diego, USA).Western Blot AnalysisWhole worm lysate was subject to electrophoresis in a 12.5% SDS-PAGE gel and transferred to a polyvinylidene difluoride membranes (Hybond P, Amersham). Blots were then probed with the primary antibody mouse anti-GFP (JL-8, Clontech) 1:2,000 overnight at 4°C. After washing, membranes were incubated for 1 hr at room temperature with horseradish-peroxidase-conjugated horse anti-mouse (Vector) 1:10,000. Western blots were developed by an enhanced chemiluminescence (ECL) detection system (Amersham). For detection of actin as loading control, membranes were stripped in Stripping buffer (1% SDS, 0.1 M Tris pH 6.8, 0.175% β-mercaptoethanol) for 30 min at 50°C, blocked and probed with mouse anti-actin (Chemicon) 1:10,000 and then incubated with horseradish-peroxidase-conjugated horse anti-mouse (Vector) 1:10,000 as described above.Immobilized Metal Ion Affinity ChromatographyProteins expressed in HEK293 cells tagged with six histidines at the C terminus were purified using a Co^2+^ affinity matrix. Secreted protein was harvested 72 hr post transfection. Conditioned medium was spun down, filtered through a 0.45 μm filter (Millipore, Durham, UK) and applied onto an Econo column (Biorad, Hemel Hempstead, UK) with Talon Metal affinity resin (TaKaRa, Saint-Germain-en-Laye, France). The flow through was aided by gravity. The column was washed with 150 mM NaCl, 20 mM Na~2~HPO~4~ pH 7.4. Protein was eluted with 500 mM imidazole in Dulbecco\'s Phosphate Buffered Saline without Ca^2+^ and Mg^2+^.Size-Exclusion Chromatography by Gel FiltrationFor separation and purification of proteins the gel filtration column Superdex 75 HiLoad26/60 (Amersham, Little Chalfont, UK) with a column volume of 320 ml connected to fast protein liquid chromatography (FPLC) system (ÄKTA, Amersham, Little Chalfont, UK) was used. Prior to gel filtration, the column was equilibrated overnight with PBS (Sigma Aldrich, Poole, UK). Proteins were loaded in PBS which was also used for rinsing the column. The flow rate was 1 ml/min, elution of proteins was monitored by spectroscopy at a wavelength of 254 nm.Analytical UltracentrifugationAnalytical ultracentrifugation was performed with a Beckman Coulter Optima XL-I analytical ultracentrifuge equipped with scanning absorbance optics. 20 μM -- 60 μM protein was studied under native conditions in PBS. UV absorbance was monitored at 280 nm. The duration of the run was 48 hr at room temperature at 17,000 rpm and 20,000 rpm, respectively. The data were fitted to an ideal monodisperse model using the program Origin (OriginLab) with a partial specific volume of 0.73 cm^3^ g^-1^ and a solvent density of 1.0054 g cm^-3^.Ka/Ks Ratio Analysis of GPSThe rate of non-synonymous substitutions (Ka) to the rate of synonymous substitutions (Ks) was determined from nucleotide sequences (138 base pairs) of the GPS of *Lphn2*, *Celsr1* and *Celsr2* from 17 species (see [Figure S4](#figs4){ref-type="fig"}). Analyses were performed with and without the coding sequence for the cleavage site (HXS/T). Data are presented as means of Ka/Ks ratios from pairwise comparisons using DnaSp v5 ([@bib48]). For statistical analysis paired t tests were performed on the basis of Ka/Ks ratios from matching species pairs.Molecular Modeling of the LAT-1 HRM3D structures of the HRM of human GLP1R were based on previously published data set (PDB: [3c59](pdb:3c59)) ([@bib31]). The structural model of the *C. elegans* LAT-1 HRM was based on [3c59](pdb:3c59) coordinates and generated by Phyre2 ([@bib45]).
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![7TM Families and Fertilization Defects of *lat-1* Mutants\
(A) Confirmed and putative (indicated by question marks) sites of ligand interaction for the five 7TM receptor families. See also [Figure S1](#figs1){ref-type="fig"}.\
(B) Gonads of a wild-type N2 and *lat-1* mutant hermaphrodites; (a) oocytes (O) pass through the spermatheca (arrowhead), become fertilized and embryogenesis ensues. Embryos (E) are visible in the uterus after spermatheca passage. (b,c) *lat-1(ok1465)* mutant hermaphrodite uteri contain a significant fraction of unfertilized oocytes, whereas oocytes in the gonads appear stacked. (d) The fertility defect of *lat-1(ok1465)* hermaphrodites can be rescued by a ΔTM2-7 transgene and by wild-type sperm from mating with wild-type males. Scale bars represent 10 μm.\
(C) Quantification of unfertilized oocytes from different genotypes. Experimental error indicated as SEM.](gr1){#fig1}

![Transgenic Rescue of *lat-1* Mutants Uncover Different Domain Requirements of the LAT-1 Receptor\
(A--C) LAT-1 receptor domain modifications exhibit different capacities to rescue lethality (circles) and fertility (boxes) of *lat-1(ok1465)* mutants. Note that the increased number of adult survivors in some transgenic lines is mainly due to increased numbers of eggs laid, whereas these constructs have little effect on the relative rate of developmental failure (gray circles). Previously published constructs are included for comparison and marked by asterisks. For numbers and detailed statistical analysis see [Tables S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}.\
(D) Deconvolved fluorescence image showing LAT-1::GFP expression at the plasma membrane of pharyngeal muscle cells (arrowheads), neurons in the nerve ring and the pharyngeal nervous system (arrows).\
(E) A ΔHRM variant exhibits an expression pattern indistinguishable from the control fusion protein in (D). Scale bars represent 10 μm. See also [Figures S2](#figs2){ref-type="fig"} and [S3](#figs3){ref-type="fig"}.](gr2){#fig2}

![The HRM of the LAT-1 Receptor Is Not Required for Ligand Binding\
(A) B1/secretin-type HRM aligned to representative HRM of aGPCR. The Cys residue in position 58 of the alignment is absent in aGPCR HRM (arrowhead). Residues forming the N-terminal α helix (a) and ligand binding pocket (b) in GLP1R are boxed. Disulfide bridges are numbered 1--3 (orange), residues that form the ligand binding interface are labeled in cyan and correspond to structures in (B) and (C). Species abbreviations: ce, *Caenorhabditis elegans*; dm, *Drosophila melanogaster*; hs, *Homo sapiens*; mb, *Monosiga brevicollis*.\
(B and C) Orthogonal views of 3D structures of the HRM of human GLP1R (B) ([@bib31]) and a structural model of the *C. elegans* LAT-1 HRM (C) derived from GLP1R data. The N-terminal α helix (a) and the extended loop (b) are boxed in the GLP1R structure (B) whereas they are both absent in the LAT-1A HRM (C).](gr3){#fig3}

![Structure but Not Autocatalytic Function of the GPS Is Required for LAT-1 Activity and Expression\
(A) Western blot of a ΔTM2-7::GFP fusion protein extracted from transgenic worm culture (N2: wild-type *C. elegans* control) show that the receptor is cleaved.\
(B) Point mutations H528A and T530A abolish cleavage activity. Full-length (arrows) and cleaved proteins (arrowheads). See also [Figure S4](#figs4){ref-type="fig"}.\
(C and D) Transgenically expressed modified LAT-1::GFP transgene products are delivered to the membrane in neurons (arrows) and pharyngeal muscle cells (arrowheads) independent of GPS cleavage (C) or exchange of the LAT-1 GPS for the LAT-2 GPS. See also [Figures S2](#figs2){ref-type="fig"} and [S3](#figs3){ref-type="fig"}. For domain nomenclature see also legend in [Figure 2](#fig2){ref-type="fig"}.\
(E) Deletion of the GPS and a missense mutation (C497S), which abolishes its structural integrity, abrogate rescuing activity of respective full-length transgenes. In contrast, mutations that leave the GPS structure unaffected possess wild-type rescue function. A heterologous GPS from LAT-2 within the LAT-1 receptor context rescues fertility but not developmental phenotypes of *lat-1(ok1465)* mutants.\
(F) The remaining rescuing function of the LAT-1/LAT-2 chimeric receptor relies on the presence of the 7TM/C terminus module but not its autocatalytic activity. For domain nomenclature see also legend in [Figure 2](#fig2){ref-type="fig"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}.](gr4){#fig4}

![Signaling of the LAT-1 Receptor via Cross-Activation in Dimeric Complex\
(A) Intermolecular complementation of the *lat-1(ok1465)* phenotype is fully achieved by pairs of donor (left) and recipient (right) LAT-1 receptors independently of GPS cleavage. The RBL domain is required in both partners. See also [Tables S1](#mmc1){ref-type="supplementary-material"} and [S4](#mmc4){ref-type="supplementary-material"}.\
(B) Analytical ultracentrifugation of LAT-1 ectodomain fractions. The N terminus contained a T530A GPS point mutation disabling cleavage but not impairing function. The receptor can adopt monomeric (left panel) and a tight dimeric form (right panel). The predicted masses of 60 kDa for a monomer and 120 kDa for a dimer were obtained from protein samples at 20°C using sedimentation equilibrium measurements.\
(C) A nonreducing polyacrylamide gel reveals a single band (60 kDa) in both monomer and dimer samples indicating that the dimeric form of the LAT-1 N terminus is not covalently linked. Additional bands smaller in size than 60 kDa indicate degraded protein.](gr5){#fig5}

![Genetic Interaction and Coexpression of *lat-1* and *ten-1*\
(A and B) Frequency of developmental (A) and fertility (B) defects in animals with different dosages of *lat-1* and *ten-1*. Genotypes ordered in ascending severity of phenotype. Experimental error indicated as SEM. See also [Table S3](#mmc3){ref-type="supplementary-material"}.\
(C and D) Expression of *lat-1::gfp* (C) and *ten-1a::gfp* (D) transgenes in epidermoblasts derived from the Caaa lineage during dorsal intercalation. Note that in Cpaaaa only *ten-1a::gfp* expression was found. Scale bars represent 10 μm.\
(E) Summary of *lat-1::gfp* and *ten-1a::gfp* activity in Caaax and Cpaaax lineages. Expressing cell, filled bullet; nonexpressing cell, open bullet.](gr6){#fig6}

![Models of LAT-1 Signaling\
(A) Summary figure of structure-function correlation for two different activities of the LAT-1 receptor. Two models of receptor function incorporate these findings.\
(B and C) Homodimerization through the RBL domain (a) initiates the 7TM-dependent LAT-1 activity (b). (B) In the bidirectional signaling model, the LAT-1 ectodomain interacts in *trans* with a molecule on the adjacent membrane through which a reverse signal (c) is conveyed to the neighboring cell. (C) The bimodal forward signaling model places LAT-1 in a *cis*-interaction with a molecule on the same cell membrane. This model accommodates a coreceptor sensing the same stimulus as the LAT-1 ectodomain and transducing a signal (c) parallel to the 7TM-dependent signal of LAT-1.](gr7){#fig7}

![Organization of the 7TM Receptor Superfamily and Protein Domain Composition in Selected aGPCR Members, Related to [Figure 1](#fig1){ref-type="fig"}.\
(A) 7TM receptors can be subgrouped according to the GRAFS classification ([@bib55]). aGPCR constitute the second largest 7TM receptor class with more than 30 members in mammalian species, which can be further classified in eight groups ([@bib43]). Only latrophilin and CELSR/Flamingo aGPCR (bold) are conserved in invertebrate genomes ([@bib24]).\
(B) Representative members of the main aGPCR groups with positions of protein domains in the N-terminus drawn to scale. Note the distance similarity of the HRM-GPS-7TM motif region (boxed in gray) among different aGPCRs. B1/Secretin receptors (bottom) contain only a HRM but no GPS, whereas the PKD1 protein (top) possesses a similar juxtamembrane GPS-7TM design as aGPCRs.\
(C) aGPCR possess a GPS (a-c) in different domain contexts: cleavable GPS-HRM (a); cleavable GPS-(no HRM)-EGF (b); non-cleavable GPS-HRM (c). B1/secretin-like receptor for comparison (d).](figs1){#figs1}

![Membrane Targeting of LAT-1::GFP Receptor Variants Is Not Impaired, Related to [Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}.\
(A--D) Confocal images show comparable sections of the terminal bulb of the adult pharynx; anterior to the left. LAT-1::GFP variants colocalize with the membrane marker FM4-64. Inset shows higher magnification of the boxed cell. Dotted arrow indicates direction and length of plot axis in A'-D'.\
(A'--D') Sectional line plots of signal intensity profiles of both channels underscores co-localization of LAT-1::GFP fusion proteins and FM4-64 intensity peaks at the membrane (M) and low signal intensities in the cytoplasm (C).\
(E) A signal generated by a soluble GFP does not overlap with the membrane marker FM4-64. Inset: higher magnification of the boxed cell. Dotted arrow indicates direction and length of plot axis in E''.\
(E') Sectional line plot of the signal intensity profile of both channels shows segregated intensity peaks for FM4-64 at the plasma membrane (M) and of *lat-1p*::GFP in the cytosol (C) indicating that both labels do not colocalize. Scale bars = 5 μm.](figs2){#figs2}

![Quantitative Analysis of Membrane Targeting of LAT-1::GFP Receptor Variants, Related to [Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}.\
(A) Confocal section through the head region of an adult worm expressing a soluble GFP chromophore under the identical *lat-1* promoter and regulatory elements which control expression of all assayed LAT-1::GFP fusion proteins. Strong GFP expression can be seen in pharyngeal muscle (arrowheads) and the nervous system (arrows). Scale bar = 10 μm.\
(B) Intensity correlation analysis of LAT-1::GFP receptor variants/FM4-64 costains. All assayed fusion proteins show dependent (i.e., colocalized) staining with the membrane marker, which is statistically indistinguishable from the LAT-1::GFP control fusion. This indicates that molecular manipulations did not disrupt membrane targeting, whereas the soluble GFP control shows segregation (i.e., non-colocalization) from the FM4-64 signal. Numbers of analyzed individuals per transgenic strain in brackets. Bold horizontal lines in the box plot represent the medians, boxes the 25% and 75% quartiles, and whiskers the minimum and maximum values of the dataset.](figs3){#figs3}

![Presence but Not Cleavage of the GPS Is Conserved in Most aGPCRs, Related to [Figure 4](#fig4){ref-type="fig"}.\
(A) Alignment of GPS with complete consensus sequence for autocatalytic cleavage. The His residue at position −2 and the S/T residues at position +1 relative to cleavage (arrowhead) are marked with arrows. The Cys residue mutated in GPR56 is in position 497 of the alignment. Residue numbering is according to the LAT-1A protein sequence.\
(B) Alignment of GPS that do not conform to the consensus sequence for autocatalytic cleavage. Note that several members of the *CELSR/Fmi* family in insects, which are orthologous to the cleavable *Drosophila* FMI, do not possess the consensus cleavage motif. Loss of cleavage activity has been experimentally confirmed for GPS of aGPCR shaded in gray. Species abbreviations: ag/Anopheles gambiae, am/Apis mellifera, ce/*Caenorhabditis elegans*, dm/*Drosophila melanogaster*, hs/*Homo sapiens*, mm/*Mus musculus*.](figs4){#figs4}
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